Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. Am J Hematol 2024 Apr;99(4):785-788
Date
02/12/2024Pubmed ID
38343182Pubmed Central ID
PMC10947844DOI
10.1002/ajh.27251Scopus ID
2-s2.0-85185139592 (requires institutional sign-in at Scopus site)Author List
Eapen M, Kou J, Andreansky M, Bhatia M, Brochstein J, Chaudhury S, Haight AE, Haines H, Jacobsohn D, Jaroscak J, Kasow KA, Krishnamurti L, Levine JE, Leung K, Margolis D, Yu LC, Horowitz MM, Kamani N, Walters MC, Shenoy SAuthors
Mary Eapen MBBS, DCh, MRCPI, MS Professor in the Medicine department at Medical College of WisconsinMary M. Horowitz MD, MS Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Anemia, Sickle CellBone Marrow Transplantation
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Humans
Unrelated Donors
